Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma

This publication has 49 references indexed in Scilit:

• Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
  Proceedings of the National Academy of Sciences, 2010
• Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
  Cancer Research, 2009
• Phase Ib Trial of Oncolytic Herpes Virus G207 Shows Safety of Multiple Injections and Documents Viral Replication
  Molecular Therapy, 2009
• Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
  Molecular Therapy, 2009
• The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas
  Clinical Cancer Research, 2008
• Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin Receptor
  PLoS Biology, 2008
• Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
  Human Gene Therapy, 2008
• Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With Cyclophosphamide
  Molecular Therapy, 2008
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
  Nature, 2006
• Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF
  Molecular Therapy, 2006